Skip to Main Content

ADVERTISEMENT

SCROLL TO CONTINUE WITH CONTENT

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Journal of Hepatology

EASL

Home
Editor's Choice
Articles and Issues
Collections
Manuscript
Journal Info
News and Media
Subscribe
EASL
More Periodicals

Advanced searchSave search

Please enter a term before submitting your search.

Submit
Log in
Register
Log in
- Submit
- Log in
Subscribe
Claim

Issue cover for Volume 71, Issue 3

September 2019

Volume 71Issue 3p449-640, e33-e48

Issue cover for Volume 71, Issue 3

Current Issue
Articles in Press
Archive
- Archive

Select all

Download started.
Ok

Please select at least one article in order to proceed.

Editorial Board

Published in issue: September 2019

i

PDF

Open access: Discover the EASL campus, e-learning platform

Published in issue: September 2019

ii

PDF

Translational research in viral hepatitis: Addressing the gaps for cure, Athens, Greece, 2020

Published in issue: September 2019

iii

PDF

Check out EASL’s webcast library

Published in issue: September 2019

iv

PDF

Prepare your application for the next EASL fellowship and mentorship programs

Published in issue: September 2019

v

PDF

Contents

Published in issue: September 2019

vii-viii

PDF

From the Editor's Desk

From the Editor’s Desk

From the Editor’s Desk

September 2019

Richard Moreau,
Ramon Bataller,
Thomas Berg,
Sophie Lotersztajn,
Jessica Zucman-Rossi,
Rajiv Jalan

Published in issue: September 2019

p449-452

Full-Text HTML
PDF

JHEP at a Glance

JHEP at a glance (September 2019)

Published in issue: September 2019

e33-e47

Online Only

PDF

Editorial

Residual risk of HCC during long-term oral nucleos(t)ide analogues (NUCs) in patients with CHB – Is one NUC better than the other?

Grace Lai-Hung Wong,
Pietro Lampertico

Published online: June 14, 2019

p453-455

Full-Text HTML
PDF
Supplemental Materials

Research Articles

Viral Hepatitis

A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea

A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea

Seung Up Kim,
Yeon Seok Seo,
Han Ah Lee,
...
Young Oh Kweon,
Beom Kyung Kim,
Soo Young Park

Published online: April 05, 2019

p456-464

Full-Text HTML
PDF
Supplemental Materials

The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study

The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study

Johann von Felden,
Laurent Alric,
Sven Pischke,
...
Jan J. Cornelissen,
Robert A. de Man,
Vincent Mallet

Published online: May 17, 2019

p465-472

Full-Text HTML
PDF
Supplemental Materials

Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis

Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis

Fanpu Ji,
Yee Hui Yeo,
Mike Tzuhen Wei,
...
Hidenori Toyoda,
Akihiro Tamori,
Mindie H. Nguyen

Published online: May 13, 2019

p473-485

Full-Text HTML
PDF
Supplemental Materials

Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study

Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study

Donna M. Evon,
Souvik Sarkar,
Jipcy Amador,
...
Carol E. Golin,
Joseph K. Lim,
Michael W. Fried

Published online: May 13, 2019

p486-497

Full-Text HTML
PDF
Supplemental Materials

A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)

A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)

Eleanor Wilson,
Emily Covert,
Jennifer Hoffmann,
...
Sarah Kattakuzhy,
Henry Masur,
Shyam Kottilil

Published online: June 04, 2019

p498-504

Full-Text HTML
PDF
Supplemental Materials

Cirrhosis

Longitudinal neurometabolic changes in the hippocampus of a rat model of chronic hepatic encephalopathy

Longitudinal neurometabolic changes in the hippocampus of a rat model of chronic hepatic encephalopathy

Olivier Braissant,
Veronika Rackayová,
Katarzyna Pierzchala,
Jocelyn Grosse,
Valérie A. McLin,
Cristina Cudalbu

Published online: June 04, 2019

p505-515

Open Access

Full-Text HTML
PDF
Supplemental Materials

Cancer

Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma

Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma

Jean-Louis Jouve,
Thierry Lecomte,
Olivier Bouché,
...
Sylvain Manfredi,
Jean-Marc Phelip
on behalf of PRODIGE-11 investigators/collaborators

Published online: May 21, 2019

p516-522

Full-Text HTML
PDF
Supplemental Materials

Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification

Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification

George N. Ioannou,
Pamela Green,
Kathleen F. Kerr,
Kristin Berry

Published online: May 27, 2019

p523-533

Full-Text HTML
PDF
Supplemental Materials

Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma

Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma

Dong Hwan Kim,
Sang Hyun Choi,
Jae Ho Byun,
...
Hyung Jin Won,
Yong Moon Shin,
Pyo-Nyun Kim

Published online: May 17, 2019

p534-542

Full-Text HTML
PDF
Supplemental Materials

Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis

Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis

Thomas Yau,
Chiun Hsu,
Tae-You Kim,
...
Jeffrey Anderson,
Christine Dela Cruz,
Masatoshi Kudo

Published online: June 06, 2019

p543-552

Open Access

Full-Text HTML
PDF
Supplemental Materials

Molecular and Cell Biology

Fetal origin confers radioresistance on liver macrophages via p21cip1/WAF1

Fetal origin confers radioresistance on liver macrophages via p21^cip1/WAF1

Radika Soysa,
Sarah Lampert,
Sebastian Yuen,
...
Wanyu Li,
Klaus Pfeffer,
Ian N. Crispe

Published online: May 08, 2019

p553-562

Full-Text HTML
PDF
Supplemental Materials

Cholestasis and Autoimmune Diseases

Contributing factors and outcomes of burn-associated cholestasis

Contributing factors and outcomes of burn-associated cholestasis

Christian de Tymowski,
François Dépret,
Sabri Soussi,
...
Vincent Mallet,
Matthieu Legrand
for the PRONOBURN group

Published online: May 29, 2019

p563-572

Full-Text HTML
PDF
Supplemental Materials

Genetic and Metabolic Diseases

Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice

Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice

Takahiro Nishio,
Ronglin Hu,
Yukinori Koyama,
...
Kojiro Taura,
David A. Brenner,
Tatiana Kisseleva

Published online: May 06, 2019

p573-585

Full-Text HTML
PDF
Supplemental Materials

Natural history of histologically proven alcohol-related liver disease: A systematic review

Natural history of histologically proven alcohol-related liver disease: A systematic review

Richard Parker,
Guruprasad P. Aithal,
Ulrik Becker,
...
Judith I. Wyatt,
Ian A. Rowe
on behalf of the WALDO study group

Published online: June 04, 2019

p586-593

Full-Text HTML
PDF
Supplemental Materials

Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration

Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration

Henry R. Wilman,
Constantinos A. Parisinos,
Naeimeh Atabaki-Pasdar,
...
Jimmy D. Bell,
Rajarshi Banerjee,
Hanieh Yaghootkar

Published online: June 18, 2019

p594-602

Open Access

Full-Text HTML
PDF
Supplemental Materials

Reviews

Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis

Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis

Manon de Krijger,
Manon E. Wildenberg,
Wouter J. de Jonge,
Cyriel Y. Ponsioen

Published online: May 17, 2019

p603-615

Full-Text HTML
PDF
Supplemental Materials

Molecular and histological correlations in liver cancer

Molecular and histological correlations in liver cancer

Julien Calderaro,
Marianne Ziol,
Valérie Paradis,
Jessica Zucman-Rossi

Published online: June 10, 2019

p616-630

Full-Text HTML
PDF
Supplemental Materials

Letters to the Editor

Unveiling the depletion of Kupffer cells in experimental hepatocarcinogenesis through liver macrophage subtype-specific markers

Unveiling the depletion of Kupffer cells in experimental hepatocarcinogenesis through liver macrophage subtype-specific markers

Sander Lefere,
Helena Degroote,
Hans Van Vlierberghe,
Lindsey Devisscher

Published online: June 15, 2019

p631-633

Full-Text HTML
PDF
Supplemental Materials

Reply to: “Unveiling the depletion of Kupffer cells in experimental hepatocarcinogenesis through liver macrophage subtype-specific markers”

Katharina Borst,
Theresa Graalmann,
Ulrich Kalinke

Published online: June 18, 2019

p633-635

Full-Text HTML
PDF
Supplemental Materials

Liver transplantation using hepatitis B core positive grafts: Which is the optimal antiviral prophylaxis?

Evangelos Cholongitas,
George V. Papatheodoridis

Published online: June 21, 2019

p635-636

Full-Text HTML
PDF
Supplemental Materials

Reply to “Liver transplantation using hepatitis B core positive grafts: Which is the optimal antiviral prophylaxis?”

Tiffany Wong,
James Fung

Published online: June 20, 2019

p636-637

Full-Text HTML
PDF
Supplemental Materials

Are liver transplant centres critical for the critically ill patient with cirrhosis?

Avik Majumdar,
Stuart K. Roberts,
David Pilcher

Published online: June 21, 2019

p637-638

Full-Text HTML
PDF
Supplemental Materials

Reply to: “Prevalence and short-term mortality in a national US cohort with acute-on-chronic liver failure”

Ruben Hernaez,
Jennifer R. Kramer,
Yan Liu,
Fasiha Kanwal

Published online: June 27, 2019

p638-639

Full-Text HTML
PDF
Supplemental Materials

EASL NAFLD Summit 2019, Sevilla, Spain

Published in issue: September 2019

IBC

PDF

Login to your account

Email/Username

Password

Forgot password?

Remember me

Don’t have an account?

Create a Free Account

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

Email*

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

The content on this site is intended for healthcare professionals.

We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.

Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

Privacy Policy
Terms and Conditions
Accessibility
Help & Contact

RELX